Table 2.
Cannabigerol Use Patterns (N=127)
| Frequency of CBG use % | Source of CBG % | Composition of products % | |||
|---|---|---|---|---|---|
| Once a month or less | 6.3 | Online | 55.9 | CBG | 73.2 |
| Once a week | 15.0 | Dispensary | 22.8 | CBD | 45.7 |
| 2–4 times a week | 26.0 | Friend | 16.5 | THC | 29.1 |
| Daily | 40.9 | Grow Myself | 8.7 | CBN | 11.8 |
| More than once daily | 11.0 | Other | 12.6 | Beta-caryophyllene | 11.8 |
| Missing | 0.8 | Limonene | 11.8 | ||
| Preferred % of CBG | % | First learned about CBG % | Myrcene | 11.8 | |
| 100% pure | 25.2 | Online article | 18.1 | Linalool | 7.1 |
| 50%–99% | 26.0 | Friend | 17.3 | Pinene | 6.3 |
| 25%–49% | 11.8 | Dispensary | 9.4 | Humulene | 6.3 |
| Any | 26.8 | Doctor | 8.7 | CBDV | 5.5 |
| Do not seek CBG | 7.9 | Nurse or other health | 5.5 | THCV | 4.7 |
| Missing | 2.4 | Care professional | Terpinolene | 2.4 | |
| Administration method % | Journal article | 6.3 | Terpineol | 1.6 | |
| Oral | 76.4 | Lecture | 3.9 | Other | 14.2 |
| Smoke | 30.7 | Podcast | 3.1 | ||
| Vape | 22.8 | Other | 26.8 | ||
| Topical | 15.7 | Missing | 0.8 | ||
| Other | 5.5 | ||||
Numbers reflect the % of the total sample (N=127) who endorsed each response.
“Frequency of CBG Use” refers to how often they use CBG-predominant products, “Preferred % of CBG” refers to the percentage of CBG they typically seek when purchasing cannabis, “Administration Method” refers to methods participants use to administer CBG-predominant cannabis, “Source of CBG” refers to where they purchase CBG-predominant products, “First Learned About CBG” refers to where they first learned about CBG-predominant products, and “Composition of Products” refers to the constituents that are in the CBG-predominant products they most often use.
CBD, cannabidiol; CBDV, cannabidivarin; CBG, cannabigerol; CBN, cannabinol; THC, tetrahydrocannabinol; THCV, tetrahydrocannabivarin.